The adipokine zinc-α2-glycoprotein activates AMP kinase in human primary skeletal muscle cells

References

• Albertus DL, Seder CW, Chen G, Wang X, Hartojo W, Lin L, Silvers A, Thomas DG, Giordano TJ, Chang AC, et al. (2008). AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. J Thorac Oncol 3, 1236–44.
   PubMed Web of Science ®Google Scholar
• Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. (2005). Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 579, 41–7.
   PubMed Web of Science ®Google Scholar
• Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, Tisdale MJ, Trayhurn P. (2004). Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 101, 2500–5.
   PubMed Web of Science ®Google Scholar
• Bing C, Russell ST, Beckett EE, Collins P, Taylor S, Barraclough R, Tisdale MJ, Williams G. (2002). Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer 86, 612–8.
   PubMed Web of Science ®Google Scholar
• Ceperuelo-Mallafre V, Naf S, Escote X, Caubet E, Gomez JM, Miranda M, Chacon MR, Gonzalez-Clemente JM, Gallart L, et al. (2009). Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity, its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab 94, 5062–9.
   PubMed Web of Science ®Google Scholar
• Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, Mackintosh C. (2008). Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 409, 449–59.
   PubMed Web of Science ®Google Scholar
• Diez-Itza I, Sanchez LM, Allende MT, Vizoso F, Ruibal A, Lopez-Otin C. (1993). Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. Eur J Cancer 29A, 1256–60
   Google Scholar
• Gao D, Trayhurn P, Bing C. (2010). Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol 325, 135–43.
   PubMed Web of Science ®Google Scholar
• Gong FY, Zhang SJ, Deng JY, Zhu HJ, Pan H, Li NS, Shi YF. (2009). Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes (Lond) 33, 1023–30.
   Web of Science ®Google Scholar
• Hale LP, Price DT, Sanchez LM, Demark-Wahnefried W, Madden JF. (2001). Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res 7, 846–53.
   PubMed Web of Science ®Google Scholar
• Hardie DG. (2003). Minireview, the AMP-activated protein kinase cascade, the key sensor of cellular energy status. Endocrinology 144, 5179–83.
   PubMed Web of Science ®Google Scholar
• Hardie DG. (2010). Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. Proc Nutr Soc 70, 92–9.
   PubMed Web of Science ®Google Scholar
• Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. (1998). Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58, 2359–65.
   PubMed Web of Science ®Google Scholar
• Irmak S, Tilki D, Heukeshoven J, Oliveira-Ferrer L, Friedrich M, Huland H, Ergun S. (2005). Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics 5, 4296–304.
   PubMed Web of Science ®Google Scholar
• Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. (1999). 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48, 1667–71.
   PubMed Web of Science ®Google Scholar
• Marrades MP, Martinez JA, Moreno-Aliaga MJ. (2008). ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 64, 61–6.
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339–43.
   PubMed Web of Science ®Google Scholar
• Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, Wilding J, Trayhurn P, Bing C. (2009). The adipokine zinc-alpha2-glycoprotein is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf) 72, 334–41.
   PubMed Web of Science ®Google Scholar
• Mracek T, Gao D, Tzanavari T, Bao Y, Xiao X, Stocker CJ, Trayhurn P, Bing C. (2010). Downregulation of zinc-{alpha}2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-{alpha} in adipocytes. J Endocrinol 204, 165–72.
   PubMed Web of Science ®Google Scholar
• Pehmoller C, Treebak JT, Birk JB, Chen S, Mackintosh C, Hardie DG, Richter EA, Wojtaszewski JF. (2009). Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab 297, E665–75
   Google Scholar
• Russell ST, Tisdale MJ. (2010a). Studies on the anti-obesity activity of zinc-alpha(2)-glycoprotein in the rat. Int J Obes (Lond). Epub ahead of print, doi:10.1038/ijo.2010.193.
   Google Scholar
• Russell ST, Tisdale MJ. (2010b). Studies on the antiobesity effect of zinc-alpha(2)-glycoprotein in the ob/ob mouse. Int J Obes (Lond). Epub ahead of print, doi:10.1038/ijo.2010.150.
   Google Scholar
• Russell ST, Zimmerman TP, Domin BA, Tisdale MJ. (2004). Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochim Biophys Acta 1636, 59–68.
   PubMed Web of Science ®Google Scholar
• Salt IP, Johnson G, Ashcroft SJ, Hardie DG. (1998). AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J 335 (Pt 3), 533–9.
   PubMedGoogle Scholar
• Sanders PM, Tisdale MJ. (2004). Effect of zinc-alpha2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue. Cancer Lett 212, 71–81.
   PubMed Web of Science ®Google Scholar
• Selva DM, Lecube A, Hernandez C, Baena JA, Fort JM, Simo R. (2009). Lower zinc-{alpha}2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 94, 4499–507.
   PubMed Web of Science ®Google Scholar
• Winder WW, Hardie DG. (1996). Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 270, E299–304
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288–95.
   PubMed Web of Science ®Google Scholar
• Zheng D, MacLean PS, Pohnert SC, Knight JB, Olson AL, Winder WW, Dohm GL. (2001). Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 91, 1073–83.
   PubMed Web of Science ®Google Scholar